Omega Therapeutics Inc
NASDAQ:OMGA
Income Statement
Earnings Waterfall
Omega Therapeutics Inc
Revenue
|
3.1m
USD
|
Operating Expenses
|
-103.4m
USD
|
Operating Income
|
-100.3m
USD
|
Other Expenses
|
2.8m
USD
|
Net Income
|
-97.4m
USD
|
Income Statement
Omega Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+178%
|
1
+80%
|
2
+53%
|
2
+13%
|
3
+12%
|
3
+9%
|
3
+9%
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(29)
|
(36)
|
(45)
|
(55)
|
(66)
|
(73)
|
(85)
|
(94)
|
(105)
|
(111)
|
(116)
|
(113)
|
(103)
|
|
Selling, General & Administrative |
(8)
|
(9)
|
(12)
|
(14)
|
(18)
|
(21)
|
(24)
|
(25)
|
(29)
|
(25)
|
(25)
|
(26)
|
(37)
|
|
Research & Development |
(21)
|
(27)
|
(34)
|
(40)
|
(48)
|
(52)
|
(61)
|
(69)
|
(76)
|
(86)
|
(91)
|
(87)
|
(66)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(29)
N/A
|
(36)
-27%
|
(45)
-25%
|
(55)
-20%
|
(66)
-21%
|
(73)
-11%
|
(84)
-15%
|
(93)
-10%
|
(103)
-11%
|
(109)
-6%
|
(114)
-5%
|
(111)
+3%
|
(100)
+9%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
2
|
3
|
3
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
Pre-Tax Income |
(29)
N/A
|
(38)
-27%
|
(47)
-24%
|
(57)
-22%
|
(68)
-20%
|
(75)
-10%
|
(85)
-14%
|
(93)
-9%
|
(103)
-11%
|
(108)
-5%
|
(112)
-4%
|
(108)
+3%
|
(97)
+10%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(29)
|
(38)
|
(47)
|
(57)
|
(68)
|
(75)
|
(85)
|
(93)
|
(103)
|
(108)
|
(112)
|
(108)
|
(97)
|
|
Net Income (Common) |
(29)
N/A
|
(38)
-27%
|
(47)
-24%
|
(57)
-22%
|
(68)
-20%
|
(75)
-10%
|
(85)
-14%
|
(93)
-9%
|
(103)
-11%
|
(108)
-5%
|
(112)
-4%
|
(108)
+3%
|
(97)
+10%
|
|
EPS (Diluted) |
-0.63
N/A
|
-0.81
-29%
|
-1
-23%
|
-1.76
-76%
|
-3.05
-73%
|
-1.56
+49%
|
-1.78
-14%
|
-1.94
-9%
|
-2.14
-10%
|
-2.12
+1%
|
-2.02
+5%
|
-1.95
+3%
|
-1.8
+8%
|